Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the use of…
NEW YORK (Reuters Health) – When target cholesterol levels are not achieved with statin monotherapy in patients with mixed dyslipidemia, adding fenofibrate can tip the scales favorably. Dr.…
NEW YORK (Reuters Health) – For children with type 1 diabetes being treated with an insulin pump, lowering the basal insulin rate after exercise reduces the occurrence of…
NEW YORK (Reuters Health) – For children and very lean adults who use a 5 mm insulin needle, angling the injection into a pinched skin fold reduces pain…
NEW YORK (Reuters Health) – Patients with type 2 diabetes who have fairly high cholesterol levels despite simvastatin treatment do better with the addition of ezetimibe, Italian investigators…
NEW YORK (Reuters Health) – Independent of the usual markers of glycemic control, the amplitude of daily glucose excursions is associated with cognitive function in elderly patients with…
NEW YORK (Reuters Health) – Among patients with metabolic syndrome and mixed dyslipidemia, treatment with fenofibric acid in combination with a statin reduces the prevalence of metabolic syndrome…
NEW YORK (Reuters Health) – Elderly men with limitations in mobility who are treated with testosterone to improve strength appear to be at increased risk of cardiovascular-related adverse…
NEW YORK (Reuters Health) – For patients with diabetes and hypertension, an antihypertensive regimen combining an ACE inhibitor with a calcium channel blocker provides better protection against cardiovascular…
NEW YORK (Reuters Health) – Balloon angioplasty, drug-eluting stents, and bare metal stents appear to be equally effective at reducing death or myocardial infarction (MI) over a year’s…